» Articles » PMID: 3337456

Pulmonary Infection with Nontuberculous Mycobacteria

Overview
Specialty Pulmonary Medicine
Date 1988 Jan 1
PMID 3337456
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Nontuberculous mycobacterial infections (NTM) are being increasingly recognized as a cause of chronic pulmonary disease. We recently reviewed the clinical, radiologic, and bacteriologic presentation of 89 adult patients ill enough to have been hospitalized between 1981 and 1985 with the diagnosis of NTM. Preexisting lung disease was present in 82% and alcohol abuse in 40%. Although M. avium complex was identified in 51% of the patients, M. xenopi, which is usually reported to occur infrequently, accounted for 38% of our cases and M. kansasii for only 9%. Treatment was limited by a high incidence of associated disease, in vitro drug resistance, drug toxicity, and a mortality rate of 32% within 18 months of admission. Nevertheless, bacteriologic conversion occurred in 29% of those treated. M. xenopi appears to be an important pathogen in southern Ontario. It differs from the other NTM by having a different pattern of in vitro drug resistance but not by its clinical or radiologic presentation.

Citing Articles

Comparison of the incidence between tuberculosis and nontuberculous mycobacterial disease after gastrectomy.

Kim C, Im K, Yoo S, Lee S, Cha S, Jung H Infection. 2014; 42(4):697-704.

PMID: 24817438 DOI: 10.1007/s15010-014-0627-z.


Prevalence of nontuberculous mycobacteria in cystic fibrosis clinics, United Kingdom, 2009.

Seddon P, Fidler K, Raman S, Wyatt H, Ruiz G, Elston C Emerg Infect Dis. 2013; 19(7):1128-30.

PMID: 23764198 PMC: 3713964. DOI: 10.3201/eid/1907.120615.


Mycobacterium xenopi: Evidence for Increased Rate of Clinical Isolation.

Bluth M, Vera R, Razeq J, Kramer M, Abu-Lawi K Int J Biomed Sci. 2013; 5(2):96-100.

PMID: 23675124 PMC: 3614773.


Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario in 2007.

Houqani M, Jamieson F, Chedore P, Mehta M, May K, Marras T Can Respir J. 2011; 18(1):19-24.

PMID: 21369546 PMC: 3071009. DOI: 10.1155/2011/865831.


Targeted delivery of amikacin into granuloma.

Montes-Worboys A, Brown S, Regev D, Bellew B, Mohammed K, Faruqi I Am J Respir Crit Care Med. 2010; 182(12):1546-53.

PMID: 20693382 PMC: 3029940. DOI: 10.1164/rccm.200912-1888OC.